课题基金 / 基金详情

Studies for Structure-Activities Relationships of Reveromycin A : An Inhibitor of Eukaryotic Cell Growth

Studies for Structure-Activities Relationships of Reveromycin A : An Inhibitor of Eukaryotic Cell Growth
真核细胞生长抑制剂Reveromycin A的构效关系研究
批准号:
14572104
负责人:
SHIMIZU Takeshi
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

SHIMIZU Takeshi的其他基金

相关文献

中文摘要
翻译
Reveromycin A是一种由链霉菌产生的新型聚酮型抗生素,可抑制小鼠表皮角质形成细胞中表皮生长因子诱导的有丝分裂活性。reveromycin A的特征性结构特征包括1,7- dioxspiro[5.5]十一烷部分,即6,6-螺缩醛体系含有半琥珀酸、两个烯基羧酸以及甲基和正丁基。制备了各种类型的左旋霉素A衍生物,并测定了它们对异酰基trna合成酶活性和体外蛋白合成的抑制作用,以及对src^<ts> NRK细胞形态逆转的活性。结果表明,C5羟基和C24羧基对这些活性尤为重要。
英文摘要
Reveromycin A is a novel polyketide-type antibiotic produced by Streptomyces sp. and inhibits mitogenic activity induced by the epidermal growth factor in a mouse epidermal keratinocyte. The characteristic structural features of reveromycin A include a 1,7-dioxaspiro[5.5]undecane moiety, that is, the 6,6-spiroacetal system bearing a hemisuccinate, two alkenyl carboxylic acids, and methyl and n-butyl groups. Various derivatives of reveromycin A were prepared and their inhibitory effects on both isoleucyl-tRNA synthetase activity and in vitro protein synthesis, and activities on the morphological reversion of src^<ts> NRK cells were assayed. It was clarified that the C5 hydroxyl group and C24 carboxyl group were particularly important for these activities.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Shimizu T., Usui T., Machida K., Furuya K., Osada H., Nakata T.: "Chemical modification of reveromycin A and its biological activities"Bioor.Med.Chem.Lett.. 12. 3363-3366 (2002)
Shimizu T.、Usui T.、Machida K.、Furuya K.、Osada H.、Nakata T.:“reveromycin A 的化学修饰及其生物活性”Bioor.Med.Chem.Lett.. 12. 3363-3366 (
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miyamoto Y, Machida K, Mizunuma M, Emoto Y, Sato N, Miyahara K, Hirata D, Usui T., Takahashi H, Osada H, Miyakawa T.: "Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A"J.Biol.Chem.
Miyamoto Y、Machida K、Mizunuma M、Emoto Y、Sato N、Miyahara K、Hirata D、Usui T.、Takahashi H、Osada H、Miyakawa T.:“酿酒酵母异亮氨酰-tRNA 合成酶作为 G1 靶点的鉴定
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuji Miyamoto: "Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor reveromycin A"J.Biol.Chem.. 277. 28810-28814 (2002)
Yuji Miyamoto:“鉴定酿酒酵母异亮氨酰-tRNA 合成酶作为 G1 特异性抑制剂白藜芦醇 A 的靶标”J.Biol.Chem.. 277. 28810-28814 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Effects of excercise continuity using motion games for groups who don't have exercise habits
    • 批准号:
      25750344
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.5万
    • 财政年份:
      2013
    • 负责人:
      SHIMIZU Takeshi
    • 依托单位:
    Molecular mechanisms that function in oligodendrocyte myelination
    Study of Shiga toxin productions us ing in vivo analysis
    • 批准号:
      21590478
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      SHIMIZU Takeshi
    • 依托单位:
    Role of lipoxin as an inhibitory mediator in upper airway inflammation
    • 批准号:
      20591999
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      SHIMIZU Takeshi
    • 依托单位: